Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study
Mashu Futagawa, Tetsuya Okazaki, Eiji Nakata, Chika Fukano, Risa Osumi, Fumino Kato, Yusaku Urakawa, Hideki Yamamoto, Toshifumi Ozaki, Akira Hirasawa · 2024
Read Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study by Mashu Futagawa, Tetsuya Okazaki, Eiji Nakata, Chika Fukano, Risa Osumi, Fumino Kato, Yusaku Urakawa, Hideki Yamamoto, Toshifumi Ozaki, Akira Hirasawa (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11599849.txt.
Description
Futagawa leads a team profiling gene variants and symptoms in Japanese neurofibromatosis patients in a 2024 cohort paper. The condition causes tumors and many other features, varying widely by person. Hereditary tumor clinics supplied the cases.
Testing found disease-causing variants in most suspected patients, and a fifth of those variants were new to science. A striking share of adults had malignancies, with breast cancer in a fifth of the women. High blood pressure was also common in adults. Patients with large gene deletions showed stronger skin, bone, and nerve features. The authors urge regular surveillance, above all for cancer and blood pressure. Genetic counseling gains from these local data. Multidisciplinary care is the closing message.
Catalog record
| CREATOR | Mashu Futagawa, Tetsuya Okazaki, Eiji Nakata, Chika Fukano, Risa Osumi, Fumino Kato, Yusaku Urakawa, Hideki Yamamoto, Toshifumi Ozaki, Akira Hirasawa |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |